Therapeutic Uses
Anti-Cancer / Oncology
Storage Condition
Store at refrigerator (2-8°C) for long term storage
Synonyms
[6-Hydroxy-2-(4-hydroxyphenyl)-benzo[b]thien-3-yl][4-[2-(1-piperidinyl)ethoxy-D4]phenyl]methanone Hydrochloride
Application Notes
Useful research chemical for a range of applications
Purity by HPLC
Not less than 90%
Hazard Compound
No -Refer MSDS for accurate information
Raloxifene-d4 Hydrochloride is a drug product that is used as an analytical standard for HPLC, as well as in research and development of drugs.
Refund Policy
We are committed to offering products of the highest quality in order to meet the needs of our customers, and have elaborate systems in
place to ensure that material specifications, their certification and all handling and storage conditions are communicated at the time of
material handover.
We have invested in the highest quality packaging materials and use international logistics partners to service our customers. While all
possible precautions have been taken to deliver the required product(s), there may be some rare situations when our product does not
meet your requirements. Should that arise, please contact us with your concerns and we will endeavour to address them on a priority
basis. If there is no other option, we will either replace your product(s) or issue a refund or account credit, whichever you prefer.
If there is an issue with one or more of our products, our policy is that it must be reported to us within 45 days of your receiving shipment.
While we will always address product issues after the 45 day return window has passed, we cannot issue a refund or account credit. As
always, we appreciate your support.
Raloxifene-d4 Hydrochloride usage and description
Raloxifene D4 Hydrochloride is a selective estrogen receptor modulator (SERM) used to treat and prevent osteoporosis in postmenopausal women. It works by binding to estrogen receptors in the bones and inhibiting the activity of osteoclasts, which are the cells responsible for breaking down bone tissue. This results in an increase in bone density and a decrease in the risk of fractures.
Chemically, Raloxifene D4 Hydrochloride is a deuterated analog of Raloxifene Hydrochloride, which means it has four deuterium atoms added to its molecular structure. Deuterium is an isotope of hydrogen that is heavier and more stable than the typical hydrogen atom. This modification is used in pharmacological research to create isotopically labeled compounds that can be used in metabolic and pharmacokinetic studies.
In terms of its chemical properties, Raloxifene D4 Hydrochloride is a white to off-white crystalline powder that is soluble in methanol and ethanol. It has a molecular weight of 510.1 g/mol and a melting point of 153-156°C.
When used as directed, Raloxifene D4 Hydrochloride has been shown to be safe and effective in preventing and treating osteoporosis in postmenopausal women. However, as with any medication, there may be side effects and contraindications that should be discussed with a healthcare provider before use.
